Global Impetigo Treatment Market 2019-2023 with Cutanea Life Sciences, GlaxoSmithKline, LEO Pharma & Medimetriks Pharmaceuticals Dominating

Dublin, Dec. 19, 2018 (GLOBE NEWSWIRE) -- The "Global Impetigo Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The impetigo treatment market will register a CAGR of about 7% by 2023.

The evolving resistance of microorganisms is likely to push growth in the market. There has been evolving resistance owing to the frequent usage of oral antibiotics. Hence manufacturers are developing more effective antibiotics to treat skin infections.

Market Overview

Low cost of treatment

Impetigo is a common, highly contagious bacterial skin infection. However, the infection can be treated easily without spending much.

Side effects of drugs

Impetigo is a bacterial infection of the skin which is treated with topical antibiotics or oral drugs. However, few side effects of these drugs may pose a challenge to the market.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Cutanea Life Sciences and GlaxoSmithKline, the competitive environment is quite intense.

Factors such as the low cost of treatment and the low cost of treatment, will provide considerable growth opportunities to impetigo treatment manufactures. Cutanea Life Sciences, GlaxoSmithKline, LEO Pharma, and Medimetriks Pharmaceuticals are some of the major companies covered in this report.

With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the markets competitive landscape and offering information on the products offered by companies.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

• Market sizing 2018
• Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• Topical - Market size and forecast 2018-2023
• Oral - Market size and forecast 2018-2023
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: SEGMENTATION BY DRUG CLASS

PART 10: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• Key leading countries
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

PART 15: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
  

• Cutanea Life Sciences
• GlaxoSmithKline
• LEO Pharma
• Medimetriks Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/rvgfff/global_impetigo?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Dermatological Drugs